SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

$RARI is an ERC-20 token that controls the RARI Foundation treasury and governs the Rarible protocol and RARI Chain. The token was issued in 2020 with a max. supply of 25 million $RARI.

Rarible

Rarible is generating significant social media buzz among retail traders who are attracted to its ultra-low circulating supply and potential for rapid volatility. Community members are actively debating the token's long-term utility versus its speculative appeal, frequently highlighting its scarcity as a primary catalyst for potential price appreciation.

Dominion Energy, Inc. engages in the production and distribution of energy. It operates through following business segments: Dominion Energy Virginia, Dominion Energy South Carolina, Contracted Energy, and Corporate and Other. The Corporate and Other segment focuses on corporate, service company, non-controlling interest in Dominion privatization, and non-regulated retail energy marketing operations. The company was founded by William W. Berry in 1983 and is headquartered in Richmond, VA.

Dominion Energy Inc

Dominion Energy is trending as investors monitor the company's $50 billion infrastructure plan and potential growth from surging data center power demand, while sentiment remains weighed by regulatory uncertainties and the impact of federal policy on its major offshore wind initiatives. The community is actively debating the company's valuation against its dividend yield and long-term execution risks as it attempts to balance renewable investments with core utility performance.

Domino's Pizza, Inc. engages in the management of a network of company-owned and franchise-owned pizza stores. It operates through the following segments: U.S. Stores, International Franchise, and Supply Chain. The U.S. Stores segment consists primarily of franchise operations. The International Franchise segment comprises a network of franchised stores. The Supply Chain segment manages regional dough manufacturing and food supply chain centers. The company was founded by James Monaghan and Thomas Stephen Monaghan in 1960 and is headquartered in Ann Arbor, MI.

Dominos Pizza Inc

Domino's Pizza is currently trending due to a mixed Q1 earnings report that featured an earnings beat but a slight revenue miss, leading to community debate over the company's valuation and the broader sustainability of the quick-service pizza model. Investors are actively discussing the impact of macro headwinds on consumer spending, potential M&A speculation, and the effectiveness of the firm's 'Hungry for MORE' strategy amidst rising competition from delivery aggregators.

ConocoPhillips is an exploration and production company, which engages in the exploration, production, transport, and marketing of crude oil, bitumen, and natural gas. It operates through the following geographical segments: Alaska, Lower 48, Canada, Europe, Middle East, and North Africa, Asia Pacific, and Other International. The Alaska segment explores for, produces, transports and markets crude oil, natural gas and NGLs. The Lower 48 segment consists of operations located in the 48 contiguous U.S. states and the Gulf of Mexico. The Canada segment refers to oil sands development in the Athabasca Region of northeastern Alberta and a liquids-rich unconventional play in western Canada. The Europe, Middle East, and North Africa segment includes operations in the Norwegian sector of the North Sea, the Norwegian Sea, Qatar, Libya, Equatorial Guinea and commercial and terminalling operations in the U.K. The Asia Pacific segment focuses on explorations and product operations in China, Indonesia, Malaysia, and Australia. The Other International segment handles exploration activities in Columbia and Argentina. The company was founded by Isaac Elder Blake on November 25, 1875 and is headquartered in Houston, TX.

Conoco Phillips

ConocoPhillips is currently trending as investors weigh significant geopolitical tensions in the Middle East and shifting U.S. energy policies under the new administration. The community is actively debating the stock's valuation, dividend reliability, and the potential impact of future Alaska drilling permits versus global supply fluctuations.

SentinelOne, Inc. engages in the provision of endpoint security software that detects, models, and predicts threat behavior to block attacks on any computing device. Its services include vigilance, support, and training. The company was founded by Tomer Weingarten and Almog Cohen in 2013 and is headquartered in Mountain View, CA.

SentinelOne Inc - Ordinary Shares - Class A

SentinelOne Inc

SentinelOne is seeing active discussion as investors weigh the company's valuation against its performance in the cybersecurity sector, with many community members debating whether it remains an undervalued buyout candidate or faces long-term headwinds. While some traders are focused on short-term price action and potential volatility surrounding upcoming earnings, others are highlighting the company's expansion into AI-driven security as a key driver for long-term growth.

Cingulate, Inc. operates as a clinical stage bio pharmaceutical company using a Precision Timed Release drug delivery platform technology to build a pipeline of next-generation pharmaceutical products. The firm initially focused on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD). It identifies and evaluates additional therapeutic areas, PTR technology employed to develop future product candidates. Cingulate was founded by Shane J. Schaffer, Craig Steven Gilgallon, Raul R. Silva, Matthew N. Brams in May 2012 and is headquartered in Kansas City, KS.

Cingulate Inc

Cingulate Inc. is trending as investors react to a recent US Patent Office notice of allowance for its lead ADHD drug candidate, CTx-1301, while closely monitoring the upcoming May 31 PDUFA date. The community is actively discussing the stock's low float and the potential for a significant price run-up as market participants weigh the impact of clinical milestones against the firm's path toward commercialization.

Pyth Network is a decentralised oracle network designed to provide real-time financial market data to decentralised applications (dApps) across multiple blockchains. It allows developer to secure smart contracts with reliable, low-latency market data from institutional sources, and build apps with high-fidelity oracle feeds designed for mission-critical systems.

Pyth Network

Pyth Network is trending due to its role as critical infrastructure for the DeFi sector, highlighted by its partnership with the U.S. Department of Commerce to provide macroeconomic data on-chain. Investors are actively discussing the project's institutional backing, its revenue-sharing model through protocol token buybacks, and its growing importance within the Real World Asset (RWA) market narrative.

Jumia Technologies AG engages in the provision of logistic services. It operates a pan-African e-commerce platform. It operates through the following geographical segments: West Africa, North Africa, East and South Africa, Europe, United Arab Emirates, and Others. The company was founded by Jeremy Hodara, Sacha Poignonnec, Peter Allerstorfer, Manuel Koser, Tunde Kehinde, and Raphael Afaedor in 2012 and is headquartered in Berlin, Germany.

Jumia Technologies Ag - ADR

Jumia Technologies is currently a major focus for traders and analysts as they anticipate upcoming earnings, with recent coverage initiating an overweight rating and highlighting the company as the potential 'Amazon of Africa.' While community sentiment remains bullish on the long-term growth and path to profitability, the stock is experiencing high volatility as investors balance excitement over these prospects against broader market pressures and the typical pre-earnings sentiment swings.

Eton Pharmaceuticals, Inc. engages in the development, acquisition, and commercialization of prescription drug products. Its products include Biorphen, Alaway Preservative Free, zonisamide oral suspension, topiramate oral suspension, lamotrigine for oral suspension, cysteine injection, and ephedrine ready-to-use injection. The company was founded in April 2017 and is headquartered in Deer Park, IL.

Eton Pharmaceuticals Inc

Eton Pharmaceuticals is trending as investors monitor recent FDA activity, including the submission of an NDA for ET-600 and the pursuit of new commercial assets like Galzin to strengthen their rare disease portfolio. Community discussions focus on the company's transition from a biotech developer to a revenue-generating entity, with many highlighting its consistent sequential growth and expressing optimism about the stock's long-term potential as they scale their commercial footprint.

Shell Plc engages in the business of producing oil and natural gas. It operates through the following segments: Integrated Gas, Upstream, Marketing, Chemicals and Products, Renewables and Energy Solutions, and Corporate. The Integrated Gas segment includes liquefied natural gas, and conversion of natural gas into gas-to-liquids fuels. The Upstream segment focuses on exploration and extraction of crude oil, natural gas, and natural gas liquids. The Marketing segment is involved in mobility, lubricants, and sectors and decarbonization businesses. The Chemicals and Products segment consists of chemicals manufacturing plants with marketing network and refineries, which turn crude oil and other feedstocks into a range of oil products. The Renewables and Energy Solutions segment provides renewable power generation, marketing, trading, and optimizing power and pipeline gas, as well as carbon credits and digitally enabled customer solutions. The Corporate segment covers non-operating activities supporting Shell such as holdings, treasury organization, self-insurance activities, and headquarters and central functions. The company was founded in February 1907 and is headquartered in London, the United Kingdom.

Shell Plc - ADR (Representing - Ordinary Shares)

Shell (SHEL) is trending as the energy major navigates high-stakes legal battles, including a significant win in its appeal against a landmark Dutch climate ruling that previously mandated aggressive emission cuts. Community discussion remains focused on Shell's strategic pivot toward LNG leadership, ongoing share buyback programs, and the broader macro implications of shifts in global energy policy.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Tema Etfs LLC Decreases Position in Revolution Medicines, Inc. $RVMD

Tema Etfs LLC trimmed its holdings in Revolution Medicines, Inc. (NASDAQ:RVMD - Free Report) by 20.7% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange...

Revolution Medicines, Inc. (NASDAQ:RVMD) Given Average Rating of "Buy" by Analysts

Shares of Revolution Medicines, Inc. (NASDAQ:RVMD - Get Free Report) have been given a consensus rating of "Buy" by the twenty-one ratings firms that are presently covering the stock, MarketBeat.com reports. One investment analyst has rated the stock with a sell recommendation, fifteen have given...

Revolution Medicines (RVMD) Down 8.8% Since Last Earnings Report: Can It Rebound?

Revolution Medicines (RVMD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Revolution Medicines Sees Unusually High Options Volume (NASDAQ:RVMD)

Revolution Medicines, Inc. (NASDAQ:RVMD - Get Free Report) was the target of unusually large options trading activity on Friday. Stock investors bought 12,797 put options on the company. This represents an increase of 131% compared to the average daily volume of 5,546 put options...

Insider Selling: Revolution Medicines (NASDAQ:RVMD) Insider Sells 2,010 Shares of Stock

Revolution Medicines, Inc. (NASDAQ:RVMD - Get Free Report) insider Xiaolin Wang sold 2,010 shares of the stock in a transaction that occurred on Tuesday, March 17th. The shares were sold at an average price of $99.48, for a total value of $199,954.80. Following the sale, the insider directly owned...

Revolution Medicines (NASDAQ:RVMD) Insider Sells 2,073 Shares

Revolution Medicines, Inc. (NASDAQ:RVMD - Get Free Report) insider Lin Wei sold 2,073 shares of the firm's stock in a transaction on Tuesday, March 17th. The stock was sold at an average price of $99.48, for a total value of $206,222.04. Following the completion of the transaction, the insider...

Revolution Medicines (NASDAQ:RVMD) Insider Sells $427,962.96 in Stock

Revolution Medicines, Inc. (NASDAQ:RVMD - Get Free Report) insider Stephen Michael Kelsey sold 4,302 shares of the stock in a transaction that occurred on Tuesday, March 17th. The stock was sold at an average price of $99.48, for a total value of $427,962.96. Following the transaction, the insider...

Insider Selling: Revolution Medicines (NASDAQ:RVMD) COO Sells 4,583 Shares of Stock

Revolution Medicines, Inc. (NASDAQ:RVMD - Get Free Report) COO Margaret Horn sold 4,583 shares of the firm's stock in a transaction dated Tuesday, March 17th. The stock was sold at an average price of $99.48, for a total transaction of $455,916.84. Following the completion of the transaction, the...

Insider Selling: Revolution Medicines (NASDAQ:RVMD) CFO Sells 2,753 Shares of Stock

Revolution Medicines, Inc. (NASDAQ:RVMD - Get Free Report) CFO Jack Anders sold 2,753 shares of the stock in a transaction that occurred on Tuesday, March 17th. The stock was sold at an average price of $99.48, for a total value of $273,868.44. Following the completion of the transaction, the chief...

Revolution Medicines (NASDAQ:RVMD) Insider Mark Goldsmith Sells 12,871 Shares

Revolution Medicines, Inc. (NASDAQ:RVMD - Get Free Report) insider Mark Goldsmith sold 12,871 shares of the firm's stock in a transaction that occurred on Tuesday, March 17th. The shares were sold at an average price of $99.48, for a total transaction of $1,280,407.08. Following the completion of...

Revolution Medicines, Inc. is a clinical-stage precision oncology company, which engages in developing novel targeted therapies. It engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment regimens to maximize the depth and durability of clinical benefit and circumvent adaptive resistance mechanisms for patients which are dependent on the RAS and mTOR pathway. The company was founded by Mark A. Goldsmith, Kevan Shokat, Martin D. Burke, David L. Pompliano and Michael Fischbach in October 2014 and is headquartered in Redwood City, CA.

Revolution Medicines Inc

Opendoor ($OPEN)

Strategy ($MSTR)

American Eagle ($AEO)

Ondas Inc. ($ONDS)

The stock that proved the power of the crowd. Fueled by community energy and social momentum, this winner captivated retail investors regardless of what the "experts" or traditional fundamentals had to say.

Fiscal Period	Estimated	Reported	Surprise	Result
Q1 '26	-$1.82	--	--	N/A
Q4 '25	-$1.58	-$1.86	-17.63%	MISSED
Q3 '25	-$1.42	-$1.61	-13.29%	MISSED
Q2 '25	-$1.12	-$1.31	-16.60%	MISSED
Q1 '25	-$1.10	-$1.13	-3.01%	MISSED

RVMD
Revolution Medicines Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q1 '26

Historical Earnings

Latest RVMD News

RVMDRevolution Medicines Inc